Acorah Software Products - Accounts Production 16.8.310 false true 30 June 2024 1 July 2023 false 1 July 2024 30 June 2025 30 June 2025 04438304 Dr S A Rudd Dr B Rudd Dr B Rudd true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 04438304 frs-core:CurrentFinancialInstruments frs-core:WithinOneYear 2025-06-30 04438304 2024-06-30 04438304 2025-06-30 04438304 2024-07-01 2025-06-30 04438304 frs-core:CurrentFinancialInstruments 2025-06-30 04438304 frs-core:Non-currentFinancialInstruments 2025-06-30 04438304 frs-core:ComputerEquipment 2025-06-30 04438304 frs-core:ComputerEquipment 2024-07-01 2025-06-30 04438304 frs-core:ComputerEquipment 2024-06-30 04438304 frs-core:FurnitureFittings 2025-06-30 04438304 frs-core:FurnitureFittings 2024-07-01 2025-06-30 04438304 frs-core:FurnitureFittings 2024-06-30 04438304 frs-core:NetGoodwill 2025-06-30 04438304 frs-core:NetGoodwill 2024-07-01 2025-06-30 04438304 frs-core:NetGoodwill 2024-06-30 04438304 frs-core:ShareCapital 2025-06-30 04438304 frs-core:RetainedEarningsAccumulatedLosses 2025-06-30 04438304 frs-bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 04438304 frs-bus:FilletedAccounts 2024-07-01 2025-06-30 04438304 frs-bus:SmallEntities 2024-07-01 2025-06-30 04438304 frs-bus:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 04438304 frs-bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 04438304 1 2024-07-01 2025-06-30 04438304 frs-bus:Director1 2024-07-01 2025-06-30 04438304 frs-bus:Director2 2024-07-01 2025-06-30 04438304 frs-bus:CompanySecretary1 2024-07-01 2025-06-30 04438304 frs-countries:EnglandWales 2024-07-01 2025-06-30 04438304 frs-core:CurrentFinancialInstruments frs-core:WithinOneYear 2024-06-30 04438304 frs-core:Non-currentFinancialInstruments frs-core:BetweenOneFiveYears 2024-06-30 04438304 2023-06-30 04438304 2024-06-30 04438304 2023-07-01 2024-06-30 04438304 frs-core:CurrentFinancialInstruments 2024-06-30 04438304 frs-core:Non-currentFinancialInstruments 2024-06-30 04438304 frs-core:ShareCapital 2024-06-30 04438304 frs-core:RetainedEarningsAccumulatedLosses 2024-06-30
Registered number: 04438304
Freedom Healthcare Limited
Financial Statements
For The Year Ended 30 June 2025
Freedom Healthcare Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—6

Page 1
Freedom Healthcare Limited
Balance Sheet
As At 30 June 2025
Balance Sheet
Registered number: 04438304

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 5 |  | 4,565 |  | 6,088
|  |  | 4,565 |  | 6,088
CURRENT ASSETS
Stocks | 6 | 500 |  | 500 |
Debtors | 7 | 11,311 |  | 8,448 |
Cash at bank and in hand |  | 3,946 |  | 10,974 |
|  | 15,757 |  | 19,922 |
Creditors: Amounts Falling Due Within One Year | 8 | (19,859 ) |  | (19,781 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | (4,102 ) |  | 141
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 463 |  | 6,229
Creditors: Amounts Falling Due After More Than One Year | 9 |  | - |  | (5,938 )
NET ASSETS |  |  | 463 |  | 291
CAPITAL AND RESERVES
Called up share capital | 11 |  | 100 |  | 100
Profit and Loss Account |  |  | 363 |  | 191
SHAREHOLDERS' FUNDS |  |  | 463 |  | 291

Page 1
Page 2
Freedom Healthcare Limited
Balance Sheet (continued)
As At 30 June 2025
For the year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Dr S A Rudd Director | Dr B Rudd Director
16 March 2026

The notes on pages 3 to 6 form part of these financial statements.
Page 2
Page 3
Freedom Healthcare Limited
Notes to the Financial Statements
For The Year Ended 30 June 2025
Notes to the Financial Statements
1. General Information
Freedom Healthcare Limited is a private company, limited by shares, incorporated in England & Wales, registered number 04438304 . The registered office is Yew Tree House, Lewes Road, Forest Row, East Sussex, RH18 5AA.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Intangible Fixed Assets and Amortisation - Goodwill
Goodwill is the difference between amounts paid on the acquisition of a business and the fair value of the separable net assets. It is amortised to profit and loss account over its estimated economic life of .... years.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Fixtures & Fittings | 25% Reducing balance
Computer Equipment | 25% Reducing balance

2.5. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
Page 3
Page 4
Freedom Healthcare Limited
Notes to the Financial Statements (continued)
For The Year Ended 30 June 2025
2.6. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Intangible Assets

| Goodwill
--- | ---
| £
Cost
As at 1 July 2024 | 30,000
As at 30 June 2025 | 30,000
Amortisation
As at 1 July 2024 | 30,000
As at 30 June 2025 | 30,000
Net Book Value
As at 30 June 2025 | -
As at 1 July 2024 | -

Page 4
Page 5
Freedom Healthcare Limited
Notes to the Financial Statements (continued)
For The Year Ended 30 June 2025
5. Tangible Assets

| Fixtures & Fittings | Computer Equipment | Total
--- | --- | --- | ---
| £ | £ | £
Cost
As at 1 July 2024 | 12,993 | 12,000 | 24,993
As at 30 June 2025 | 12,993 | 12,000 | 24,993
Depreciation
As at 1 July 2024 | 12,811 | 6,094 | 18,905
Provided during the period | 46 | 1,477 | 1,523
As at 30 June 2025 | 12,857 | 7,571 | 20,428
Net Book Value
As at 30 June 2025 | 136 | 4,429 | 4,565
As at 1 July 2024 | 182 | 5,906 | 6,088

6. Stocks

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Stock | 500 |  | 500

7. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Other debtors | 11,311 |  | 8,448

8. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Bank loans and overdrafts | 5,783 |  | 6,003
Other creditors | 4,506 |  | 4,389
Taxation and social security | 9,570 |  | 9,389
| 19,859 |  | 19,781

9. Creditors: Amounts Falling Due After More Than One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Bank loans | - |  | 5,938

Page 5
Page 6
Freedom Healthcare Limited
Notes to the Financial Statements (continued)
For The Year Ended 30 June 2025
10. Loans
An analysis of the maturity of loans is given below:

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Amounts falling due within one year or on demand:
Bank loans | 5,783 |  | 6,003

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Amounts falling due between one and five years:
Bank loans | - |  | 5,938

11. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 100 |  | 100

12. Directors Advances, Credits and Guarantees
Included in other debtorrs due within one year are loans to the directors, Dr SA Rudd and Dr B Rudd amounting to £11,311 (2024 - £8,448).
13. Controlling Parties
The company was controlled throughout the current and previous period by its directors, Dr S A Rudd and
Dr B Rudd, by virtue of the fact that between them they own all of the company’s ordinary issued share
capital.
Page 6